Page 58 - Macromolecular Crystallography
P. 58

AU TOMATION OF CRYS TALLIZATION TECHNIQUES  47

        Ducruix and Giegé, 1999; Chayen, 2005; Bergfors,  Chayen, 2003). Uses of such phase diagrams are
        1999). However, the ideal experiment does not often  described in Sections 3.5.1 to 3.7.
        happen and more often than not, excess nucleation
        occurs, resulting in the formation of numerous,
        low-quality crystals. The aim is therefore to devise  3.4 Automation and miniaturization
        methods that will enable the experimenter to lead  of screening procedures
        the experiment from nucleation to growth, in order
                                                     There have never been any set rules or recipes
        to ensure the desired results.
                                                     to determine where to start when attempting to
                                                     crystallize a new protein, hence the most common
                                                     means to get started is by using multifactorial
        3.3 Practical considerations                 screens, in other words by exposing different
                                                     concentrations of the protein to be crystallized to
        Although phase diagrams offer one of the basic and
                                                     numerous different crystallization agents, buffers,
        most important pieces of knowledge necessary for
                                                     temperatures, etc., usually in combinations that
        growing protein crystals in a rational way, they
                                                     have been successful with other proteins. Automa-
        are not often employed because accurate quanti-
                                                     tion of screening procedures (e.g. Chayen et al., 1990;
        tative phase diagrams require numerous solubility
                                                     Weber, 1990; Soriano and Fontecilla-Camps, 1993)
        measurements. (The solubility is defined as the
                                                     began in the 1990s but only became wide spread
        concentration of protein in the solute that is in
                                                     with the appearance of structural genomics, for
        equilibrium with crystals.) Reaching equilibrium
                                                     which automation has become vital. Robotics are
        can take several months because proteins diffuse
                                                     now available for most methods of crystallization
        slowly. An additional limiting factor is that solubil-
                                                     (e.g. Luft et al., 2003; Mueller et al., 2001; Walter et
        ity measurements require large amounts of sample
                                                     al., 2003; Santarsiero et al., 2002; Chayen et al., 1992).
        (Ataka, 1993; Chayen et al., 1996).
          The area of conditions called the ‘metastable
        zone’ is situated between the solubility and super-  3.4.1 The microbatch method
        solubility curves on the crystallization phase dia-
        gram (Fig. 3.1). The supersolubility curve is defined  The first semi-high-throughput automated system
        as the line that separates the conditions where spon-  to dispense crystallization trials of less than 1µl
        taneous nucleation (or phase separation or precipi-  was designed in 1990 to deliver batch trials under
        tation) occurs, from those where the crystallization  oil (Chayen et al., 1990). The method was named
        solution remains clear if left undisturbed (Ducruix  microbatch to define a microscale batch experiment.
        and Giegé, 1992; Ducruix and Giegé, 1999).   It was designed to obtain maximum information
          The supersolubility curve is less well defined  on the molecule to be crystallized while using
        than the solubility curve but, experimentally, it is  minimal amounts of sample. In order to prevent
        found to a reasonable approximation much more  the evaporation of such small volumes, the trials
        easily. It has been reported that for practical pur-  are dispensed and incubated under low density
                                                             3
        poses, it is sufficient to obtain the supersolubility  (0.87 g/cm ) paraffin oil (Fig. 3.2). The crystalliza-
        curve. To construct it, one must set up crystalliza-  tion drops remain under the oil since the aqueous
        tion trials, varying at least two conditions (one of  drops are denser than the paraffin oil.
        which is typically the protein concentration) and  Microbatch can be performed either manually or
        plot their outcomes on a two-dimensional param-  automatically (Chayen et al., 1992). It is the simplest
        eter grid. The supersolubility curve can be obtained  crystallization method and therefore can be easily
        rapidly using robots and can aid in the separation  performed in high-throughput trials. Current robots
        of nucleation and growth using seeding and other  can dispense microbatch trials down to 1 nl volumes.
        means. A diagram containing the supersolubility  Depending on the type of oils used to cover the trials,
        curve (and not the solubility curve) is called a ‘work-  this technique can be harnessed for both screening
        ing phase diagram’ (Chayen, 2005; Saridakis and  and optimization experiments.
   53   54   55   56   57   58   59   60   61   62   63